Capa/PortadaYahoo FinancePortadaTelix Pharmaceuticals (TLX) Doses First Patient in Phase 3 Trial for Brain Cancer TherapyRRedacciónRedação · Hace 3 hLeitura 2 minLer a nota completa em Yahoo Finance